Latest filing published 21 Sept 2026 for Veracyte, INC., €139k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John Leite appears in our data through filings on Veracyte, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 4 June 2026 to 21 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 21 September 2026: a transaction of €139k, in Veracyte, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations